Cargando…

Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA

Our study was focused on the synthesis of selective mesoporous silica nanoparticles (MSNs: MCM-41, MCM-48, SBA-15, PHTS, MCF) that are widely studied for drug delivery. The resulting mesoporous surfaces were conveniently prepared making use of verified synthetic procedures. The MSNs thus obtained we...

Descripción completa

Detalles Bibliográficos
Autores principales: Swar, Sumita, Máková, Veronika, Stibor, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804163/
https://www.ncbi.nlm.nih.gov/pubmed/31574906
http://dx.doi.org/10.3390/ma12193202
_version_ 1783461119849922560
author Swar, Sumita
Máková, Veronika
Stibor, Ivan
author_facet Swar, Sumita
Máková, Veronika
Stibor, Ivan
author_sort Swar, Sumita
collection PubMed
description Our study was focused on the synthesis of selective mesoporous silica nanoparticles (MSNs: MCM-41, MCM-48, SBA-15, PHTS, MCF) that are widely studied for drug delivery. The resulting mesoporous surfaces were conveniently prepared making use of verified synthetic procedures. The MSNs thus obtained were characterized by Brunauer-Emmett-Teller (BET) analysis and scanning electron microscopy (SEM). The selected MSNs with various pore diameters and morphologies were examined to evaluate the capability of L-DOPA drug loading and release. L-DOPA is a well-known drug for Parkinson’s disease. The L-DOPA drug loading and release profiles were measured by UV-VIS spectroscopy and SBA-15 was proved to be the most effective amongst all the different types of tested mesoporous silica materials as L-DOPA drug vehicle.
format Online
Article
Text
id pubmed-6804163
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68041632019-11-18 Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA Swar, Sumita Máková, Veronika Stibor, Ivan Materials (Basel) Article Our study was focused on the synthesis of selective mesoporous silica nanoparticles (MSNs: MCM-41, MCM-48, SBA-15, PHTS, MCF) that are widely studied for drug delivery. The resulting mesoporous surfaces were conveniently prepared making use of verified synthetic procedures. The MSNs thus obtained were characterized by Brunauer-Emmett-Teller (BET) analysis and scanning electron microscopy (SEM). The selected MSNs with various pore diameters and morphologies were examined to evaluate the capability of L-DOPA drug loading and release. L-DOPA is a well-known drug for Parkinson’s disease. The L-DOPA drug loading and release profiles were measured by UV-VIS spectroscopy and SBA-15 was proved to be the most effective amongst all the different types of tested mesoporous silica materials as L-DOPA drug vehicle. MDPI 2019-09-30 /pmc/articles/PMC6804163/ /pubmed/31574906 http://dx.doi.org/10.3390/ma12193202 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Swar, Sumita
Máková, Veronika
Stibor, Ivan
Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA
title Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA
title_full Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA
title_fullStr Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA
title_full_unstemmed Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA
title_short Effectiveness of Diverse Mesoporous Silica Nanoparticles as Potent Vehicles for the Drug L-DOPA
title_sort effectiveness of diverse mesoporous silica nanoparticles as potent vehicles for the drug l-dopa
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804163/
https://www.ncbi.nlm.nih.gov/pubmed/31574906
http://dx.doi.org/10.3390/ma12193202
work_keys_str_mv AT swarsumita effectivenessofdiversemesoporoussilicananoparticlesaspotentvehiclesforthedrugldopa
AT makovaveronika effectivenessofdiversemesoporoussilicananoparticlesaspotentvehiclesforthedrugldopa
AT stiborivan effectivenessofdiversemesoporoussilicananoparticlesaspotentvehiclesforthedrugldopa